Cargando…
Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report
BACKGROUND: Scarless healing comprises the ultimate goal after an injury. Since tendon healing results in a fibrotic scar, an injured tendon can never regain the mechanical potential and strength of its uninjured form. A wide variety of studies focus on the tendon healing with an absent or minimal p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514950/ https://www.ncbi.nlm.nih.gov/pubmed/36177054 http://dx.doi.org/10.1155/2022/4250771 |
_version_ | 1784798383677898752 |
---|---|
author | Kayiran, Oguz Tunc, Suphan Ozcan, Guler Gamze Eren Kaya, Neslihan Karabulut, Derya |
author_facet | Kayiran, Oguz Tunc, Suphan Ozcan, Guler Gamze Eren Kaya, Neslihan Karabulut, Derya |
author_sort | Kayiran, Oguz |
collection | PubMed |
description | BACKGROUND: Scarless healing comprises the ultimate goal after an injury. Since tendon healing results in a fibrotic scar, an injured tendon can never regain the mechanical potential and strength of its uninjured form. A wide variety of studies focus on the tendon healing with an absent or minimal peritendinous adhesions. However, no simple method has managed it at all. Possible complex actions and peritendinous environmental events take place during the tendon healing process. Tamoxifen (TAM), besides its breast cancer-related usage, is a potent antifibrotic drug. Here, we aimed to reduce the peritendinous adhesion with TAM administration. METHODS: Achilles tendons of 44 Wistar albino rats were randomly distributed in 4 groups. In group 1, bilateral lower extremities were used as control and sham. Groups 2 and 3 were comprised of low-dose (1 mg/kg) and high-dose (40 mg/kg) systemic administration of TAM, respectively. Group 4 included local administration (1 mg/kg) of TAM. Biomechanical, macroscopical, and histopathological analyses were done and compared statistically. Biomechanically, the maximum force that led to tendon rupture was determined, and tensile force data were recorded via tensile testing device. Macroscopical and histopathological analysis were composed of the quantity, quality, and grade of peritendinous adhesions. RESULTS: Macroscopic and histopathologic findings revealed that groups 2 and 3 had a variety of values ranging between slight to severe adhesions. In group 2, almost half of the animals had moderate adhesions, whereas in group 3, the majority of the animals had moderate adhesions. There were no animals with moderate or severe adhesions in group 4. Statistically significant values were calculated between sham and control groups. Biomechanically, group 2 showed the most significant result. The tendons in group 2 had the highest stiffness when maximal force was applied to rupture the tendons. Henceforth, all these consequences were proven statistically. CONCLUSION: We achieved less peritendinous adhesion with the local administration of TAM when compared to systemic administration of TAM. A better understanding of the peritendinous environmental process will reveal to develop new therapies in the prevention of peritendinous adhesions. |
format | Online Article Text |
id | pubmed-9514950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95149502022-09-28 Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report Kayiran, Oguz Tunc, Suphan Ozcan, Guler Gamze Eren Kaya, Neslihan Karabulut, Derya Biomed Res Int Research Article BACKGROUND: Scarless healing comprises the ultimate goal after an injury. Since tendon healing results in a fibrotic scar, an injured tendon can never regain the mechanical potential and strength of its uninjured form. A wide variety of studies focus on the tendon healing with an absent or minimal peritendinous adhesions. However, no simple method has managed it at all. Possible complex actions and peritendinous environmental events take place during the tendon healing process. Tamoxifen (TAM), besides its breast cancer-related usage, is a potent antifibrotic drug. Here, we aimed to reduce the peritendinous adhesion with TAM administration. METHODS: Achilles tendons of 44 Wistar albino rats were randomly distributed in 4 groups. In group 1, bilateral lower extremities were used as control and sham. Groups 2 and 3 were comprised of low-dose (1 mg/kg) and high-dose (40 mg/kg) systemic administration of TAM, respectively. Group 4 included local administration (1 mg/kg) of TAM. Biomechanical, macroscopical, and histopathological analyses were done and compared statistically. Biomechanically, the maximum force that led to tendon rupture was determined, and tensile force data were recorded via tensile testing device. Macroscopical and histopathological analysis were composed of the quantity, quality, and grade of peritendinous adhesions. RESULTS: Macroscopic and histopathologic findings revealed that groups 2 and 3 had a variety of values ranging between slight to severe adhesions. In group 2, almost half of the animals had moderate adhesions, whereas in group 3, the majority of the animals had moderate adhesions. There were no animals with moderate or severe adhesions in group 4. Statistically significant values were calculated between sham and control groups. Biomechanically, group 2 showed the most significant result. The tendons in group 2 had the highest stiffness when maximal force was applied to rupture the tendons. Henceforth, all these consequences were proven statistically. CONCLUSION: We achieved less peritendinous adhesion with the local administration of TAM when compared to systemic administration of TAM. A better understanding of the peritendinous environmental process will reveal to develop new therapies in the prevention of peritendinous adhesions. Hindawi 2022-09-20 /pmc/articles/PMC9514950/ /pubmed/36177054 http://dx.doi.org/10.1155/2022/4250771 Text en Copyright © 2022 Oguz Kayiran et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kayiran, Oguz Tunc, Suphan Ozcan, Guler Gamze Eren Kaya, Neslihan Karabulut, Derya Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report |
title | Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report |
title_full | Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report |
title_fullStr | Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report |
title_full_unstemmed | Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report |
title_short | Tamoxifen Prevents Peritendinous Adhesions: A Preliminary Report |
title_sort | tamoxifen prevents peritendinous adhesions: a preliminary report |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514950/ https://www.ncbi.nlm.nih.gov/pubmed/36177054 http://dx.doi.org/10.1155/2022/4250771 |
work_keys_str_mv | AT kayiranoguz tamoxifenpreventsperitendinousadhesionsapreliminaryreport AT tuncsuphan tamoxifenpreventsperitendinousadhesionsapreliminaryreport AT ozcangulergamzeeren tamoxifenpreventsperitendinousadhesionsapreliminaryreport AT kayaneslihan tamoxifenpreventsperitendinousadhesionsapreliminaryreport AT karabulutderya tamoxifenpreventsperitendinousadhesionsapreliminaryreport |